Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma

NCT06199752 is registered in ClinicalTrials.gov with Theodor Bilharz Research Institute as lead sponsor.

NCT NCT06199752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06199752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma
Lead sponsor
Theodor Bilharz Research Institute
Phase
Phase 4
Overall status
Completed
Start date
December 12, 2021
Completion date
September 10, 2023
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma